Pasin, Chloé
Weil, Benjamin
Hayes, Rosalie
Siddiqui, Qaisar
Whelan, Isabelle
Nutland, Will
Maatouk, Ismael
Orkin, Chloe M
Paparini, Sara
Funding for this research was provided by:
World Health Organization
Article History
Received: 23 June 2025
Accepted: 28 August 2025
First Online: 31 October 2025
Declarations
:
: Ethics approval for the study was obtained from the Queen Mary Ethics of Research Committee on 13 March 2023 (QMERC22.045). All participants received a participant information sheet and gave written and verbal informed consent to take part in the study.
: Not applicable.
: CMO has received honoraria for advisory boards, lectureships and travel sponsorships from Janssen, Gilead Sciences, ViiV Healthcare, MSD and Bavarian Nordic and has received research grants from Janssen, Gilead Sciences, ViiV Healthcare, MSD and AstraZeneca. SP has received research grants from Gilead Sciences and ViiV Healthcare. The remaining authors (CP, BW, RH, QS, IW, WN and IM) declare that they have no competing interests.